Hearing Loss in Children with 22q11.2 Deletion Syndrome.
22q11.2 deletion syndrome
chronic otitis media
hearing loss
myringotomy tube placement
pediatric
Journal
The Laryngoscope
ISSN: 1531-4995
Titre abrégé: Laryngoscope
Pays: United States
ID NLM: 8607378
Informations de publication
Date de publication:
21 Sep 2024
21 Sep 2024
Historique:
revised:
16
08
2024
received:
24
05
2024
accepted:
05
09
2024
medline:
21
9
2024
pubmed:
21
9
2024
entrez:
21
9
2024
Statut:
aheadofprint
Résumé
Hearing loss is considered common in children with 22q11.2 deletion syndrome (22q11.2DS), with a few prior studies reporting a 32%-78% prevalence; mild-moderate conductive hearing loss has been reported most commonly. Overall, however, there remains a paucity of data regarding the frequency, type, age, and progression of hearing loss in children with 22q11.2DS. Retrospective chart review was completed, and data combined for two large 22q centers. Inclusion criteria were children with 22q11.2DS and a documented audiogram. Data extracted included a laboratory-confirmed chromosome 22q11.2 deletion; co-morbidities; results of all audiograms and radiologic temporal bone imaging; and otologic surgical procedures. One thousand seven hundred sixty-nine charts were reviewed; 775 met inclusion criteria. Of these, 563 (73%) children had at least one abnormal audiogram demonstrating hearing loss. A total of 2,536 audiograms were reviewed; 74% of these showed abnormal hearing in at least one ear. Most of the hearing loss was conductive (right ear 76%; left ear 69%) and mild severity. For the children with SNHL, 90% of all follow-up audiograms were stable without progression. Hearing loss was identified across all pediatric age ranges. Ear tube placement occurred in 39% of children. This study confirms the high incidence of hearing loss for children with 22q11.2DS at some point in their childhood. In our cohort, hearing loss occurred in 73% of children and was most often conductive and mild in severity. The results highlight the importance of otolaryngology and audiology involvement in managing children with 22q11.2DS for timely diagnosis and treatment of hearing loss. 4 Laryngoscope, 2024.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2024 The American Laryngological, Rhinological and Otological Society, Inc.
Références
Blagojevic C, Heung T, Theriault M, et al. Estimate of the contemporary live‐birth prevalence of recurrent 22q11.2 deletions: a cross‐sectional analysis from population‐based newborn screening. CMAJ Open. 2021;9(3):E802‐E809. https://doi.org/10.9778/cmajo.20200294.
Grasso F, Cirillo E, Quaremba G, et al. Otolaryngological features in a cohort of patients affected with 22q11.2 deletion syndrome: a monocentric survey. Am J Med Genet A. 2018;176(10):2128‐2134. https://doi.org/10.1002/ajmg.a.40518.
Ford LC, Sulprizio SL, Rasgon BM. Otolaryngological manifestations of velocardiofacial syndrome: a retrospective review of 35 patients. Laryngoscope. 2000;110(3 Pt 1):362‐367. https://doi.org/10.1097/00005537-200003000-00006.
Jiramongkolchai P, Kumar MS, Chinnadurai S, Wootten CT, Goudy SL. Prevalence of hearing loss in children with 22q11.2 deletion syndrome. Int J Pediatr Otorhinolaryngol. 2016;87:130‐133. https://doi.org/10.1016/j.ijporl.2016.06.005.
Digilio MC, Pacifico C, Tieri L, Marino B, Giannotti A, Dallapiccola B. Audiological findings in patients with microdeletion 22q11 (di George/velocardiofacial syndrome). Br J Audiol. 1999;33(5):329‐333. https://doi.org/10.3109/03005369909090116.
Dyce O, McDonald‐McGinn D, Kirschner RE, Zackai E, Young K, Jacobs IN. Otolaryngologic manifestations of the 22q11.2 deletion syndrome. Arch Otolaryngol Head Neck Surg. 2002;128(12):1408‐1412. https://doi.org/10.1001/archotol.128.12.1408.
Persson C, Friman V, Oskarsdottir S, Jonsson R. Speech and hearing in adults with 22q11.2 deletion syndrome. Am J Med Genet A. 2012;158A(12):3071‐3079. https://doi.org/10.1002/ajmg.a.35589.
Bassett AS, Chow EW, Husted J, et al. Clinical features of 78 adults with 22q11 deletion syndrome. Am J Med Genet A. 2005;138(4):307‐313. https://doi.org/10.1002/ajmg.a.30984.
Van Eynde C, Swillen A, Lambeens E, et al. Prevalence and nature of hearing loss in 22q11.2 deletion syndrome. J Speech Lang Hear Res. 2016;59(3):583‐589. https://doi.org/10.1044/2015_JSLHR-H-15-0098.
Verheij E, Derks LSM, Stegeman I, Thomeer H. Prevalence of hearing loss and clinical otologic manifestations in patients with 22q11.2 deletion syndrome: a literature review. Clin Otolaryngol. 2017;42(6):1319‐1328. https://doi.org/10.1111/coa.12874.
Suzuki N, Kanzaki S, Suzuki T, Ogawa K, Yamagishi H. Clinical features of 22q11.2 deletion syndrome related to hearing and communication. Acta Otolaryngol. 2020;140(9):736‐740. https://doi.org/10.1080/00016489.2020.1769862.
von Scheibler E, Widdershoven JCC, van Barneveld D, et al. Hearing loss and history of otolaryngological conditions in adults with microdeletion 22q11.2. Am J Med Genet A. 2024;194(3):e63456. https://doi.org/10.1002/ajmg.a.63456.
Reyes MR, LeBlanc EM, Bassila MK. Hearing loss and otitis media in velo‐cardio‐facial syndrome. Int J Pediatr Otorhinolaryngol. 1999;47(3):227‐233. https://doi.org/10.1016/s0165-5876(98)00180-3.
Loos E, Verhaert N, Willaert A, et al. Malformations of the middle and inner ear on CT imaging in 22q11 deletion syndrome. Am J Med Genet A. 2016;170(11):2975‐2983. https://doi.org/10.1002/ajmg.a.37872.
Weir FW, Wallace SA, White DR, Hatch JL, Nguyen SA, Meyer TA. Otologic and Audiologic outcomes in pediatric patients with Velo‐cardio‐facial (22q11 deletion) syndrome. Otol Neurotol. 2017;38(1):73‐78. https://doi.org/10.1097/MAO.0000000000001226.
Kloosterman N, Freeman MH, Belcher RH. Assessing complication risk of pressure equalizing tube placement in children with Velocardiofacial syndrome (22q11.2 deletion syndrome/DiGeorge syndrome). Ann Otol Rhinol Laryngol. 2024;133(2):224‐228. https://doi.org/10.1177/00034894231202063.
Effects of Hearing Loss on Development. 2015. https://www.asha.org/siteassets/ais/ais-hearing-loss-development-effects.pdf
Solot CB, Sell D, Mayne A, et al. Speech‐language disorders in 22q11.2 deletion syndrome: best practices for diagnosis and management. Am J Speech Lang Pathol. 2019;28(3):984‐999. https://doi.org/10.1044/2019_AJSLP-16-0147.
Boot E, Oskarsdottir S, Loo JCY, et al. Updated clinical practice recommendations for managing adults with 22q11.2 deletion syndrome. Genet Med. 2023;25(3):100344. https://doi.org/10.1016/j.gim.2022.11.012.
Harris PA, Taylor R, Minor BL, et al. The REDCap consortium: building an international community of software platform partners. J Biomed Inform. 2019;95:103208. https://doi.org/10.1016/j.jbi.2019.103208.
Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap) – a metadata‐driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42(2):377‐381. https://doi.org/10.1016/j.jbi.2008.08.010.
Oskarsdottir S, Boot E, Crowley TB, et al. Updated clinical practice recommendations for managing children with 22q11.2 deletion syndrome. Genet Med. 2023;25(3):100338. https://doi.org/10.1016/j.gim.2022.11.006.
Jackson O, Crowley TB, Sharkus R, et al. Palatal evaluation and treatment in 22q11.2 deletion syndrome. Am J Med Genet A. 2019;179(7):1184‐1195. https://doi.org/10.1002/ajmg.a.61152.
Kogan MD, Overpeck MD, Hoffman HJ, Casselbrant ML. Factors associated with tympanostomy tube insertion among preschool‐aged children in the United States. Am J Public Health. 2000;90(2):245‐250. https://doi.org/10.2105/ajph.90.2.245.
Verheij E, Elden L, Crowley TB, et al. Anatomic malformations of the middle and inner ear in 22q11.2 deletion syndrome: case series and literature review. AJNR Am J Neuroradiol. 2018;39(5):928‐934. https://doi.org/10.3174/ajnr.A5588.
Wu SS, Mahomva C, Sawaf T, et al. Association of ear Anomalies and Hearing Loss among Children with 22q11.2 deletion syndrome. Otolaryngol Head Neck Surg. 2023;168(4):856‐861. https://doi.org/10.1177/01945998221094219.
Tian C, Johnson KR. TBX1 is required for normal stria vascularis and semicircular canal development. Dev Biol. 2020;457(1):91‐103. https://doi.org/10.1016/j.ydbio.2019.09.013.
Arnold JS, Braunstein EM, Ohyama T, et al. Tissue‐specific roles of Tbx1 in the development of the outer, middle and inner ear, defective in 22q11DS patients. Hum Mol Genet. 2006;15(10):1629‐1639. https://doi.org/10.1093/hmg/ddl084.
Chen L, Fulcoli FG, Tang S, Baldini A. Tbx1 regulates proliferation and differentiation of multipotent heart progenitors. Circ Res. 2009;105(9):842‐851. https://doi.org/10.1161/CIRCRESAHA.109.200295.
Bassett AS, McDonald‐McGinn DM, Devriendt K, et al. Practical guidelines for managing patients with 22q11.2 deletion syndrome. J Pediatr. 2011;159(2):332‐339e1. https://doi.org/10.1016/j.jpeds.2011.02.039.